Fundz

Nccn Announces Funding For Prostate Cancer Research Projects, In Collaboration With Pfizer And Astellas

PRIVATENov 04, 2021

Round Type

Funding Round

Plymouth MeetingBiotechnologyHealth CareEducationMedicalNon Profit

Description

The National Comprehensive Cancer Network® (NCCN®) Oncology Research Program (ORP) today announced projects awarded to develop innovative and impactful studies that address unmet needs, as well as support the design and performance of enzalutamide research, in the treatment of prostate cancer. Grant funding will be provided by Pfizer Global Medical Grants (Pfizer) and Astellas Pharma Global Development (Astellas).

Quick answer

National Comprehensive Cancer Network raised an undisclosed amount in a Funding Round round, dated November 4, 2021. National Comprehensive Cancer Network is based in Plymouth Meeting, Pennsylvania, United States.

How much did National Comprehensive Cancer Network raise?
National Comprehensive Cancer Network raised an undisclosed amount in a Funding Round round on November 4, 2021.
What does National Comprehensive Cancer Network do?
The National Comprehensive Cancer Network® (NCCN®) is marking 30 years as a not-for-profit alliance of leading cancer centers devoted to patient care, research, and education.
Where is National Comprehensive Cancer Network based and how big is it?
National Comprehensive Cancer Network is based in Plymouth Meeting, Pennsylvania, United States. Fundz records about 180 employees.
Who are the decision-makers at National Comprehensive Cancer Network?
Fundz holds 3 contacts at National Comprehensive Cancer Network, including the Executive Director. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Education and Medical around the same time

Companies in the same sectors as National Comprehensive Cancer Network that raised within 45 days of this round, from Fundz verified event records.

  • Quartet Health, Inc. raised $81M on December 17, 2021.
  • Tasso raised $100M (Series B) on December 16, 2021.
  • Conavi Medical raised an undisclosed amount (Funding Round) on December 15, 2021.
  • Route 92 Medical raised $111M (Series E) on December 14, 2021.
  • medimaps group S.A raised $20M (Funding Round) on December 1, 2021.
  • Acrivon Therapeutics raised $100M on November 23, 2021.

Who to call at National Comprehensive Cancer Network, and when

A new round usually means National Comprehensive Cancer Network is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day National Comprehensive Cancer Network raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at National Comprehensive Cancer Network, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at National Comprehensive Cancer Network. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

National Comprehensive Cancer Network

Location

Plymouth Meeting, Pennsylvania, United States

About

The National Comprehensive Cancer Network® (NCCN®) is marking 30 years as a not-for-profit alliance of leading cancer centers devoted to patient care, research, and education. NCCN is dedicated to defining and advancing quality, effective, equitable, and accessible cancer care and prevention so all people can live better lives. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) provide transparent, evidence-based, expert consensus-driven recommendations for cancer treatment, prevention, and supportive services; they are the recognized standard for clinical direction and policy in cancer management and the most thorough and frequently-updated clinical practice guidelines available in any area of medicine. The NCCN Guidelines for Patients® provide expert cancer treatment information to inform and empower patients and caregivers, through support from the NCCN Foundation®. NCCN also advances continuing education, global initiatives, policy, and research collaboration and publication in oncology.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment National Comprehensive Cancer Network raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

3 contacts
Verified contactsPatrick D., Executive Director hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for National Comprehensive Cancer Network's next move

See what Strategic adds

National Comprehensive Cancer Network raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.